ATF6-mediated signaling contributes to PARP Inhibitor Resistance in Ovarian Cancer.

Published in Molecular Cancer Research, 2022

Recommended citation: McMellen, A., Yamamoto, T.M., Qamar, L., Sanders, B.E., Nguyen, L.L, Ortiz Chavez, D., Bapat, J., Berning, A., Post, M.D., Johnson, J., Behbakht, K., Nurmemmedov, E., Bitler, B.G. ATF6-mediated signaling contributes to PARP Inhibitor Resistance in Ovarian Cancer. Manuscript in press, Molecular Cancer Research.